Goldman Sachs Group »

Candel Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $113k 18k 6.20
2022-06-30 $33k 10k 3.29
2022-03-31 $53k 11k 5.04
2021-12-31 $83k 11k 7.84